Events

“Oncology Reimbursement Trends and Their Impact on Early Stage Product Investments and Partnerships”

Reimbursement Intelligence cordially invites you to an informative breakfast session during the American Society of Clinical Oncology’s (ASCO) Annual Conference in Chicago.

Monday, June 2, 2008

Fill in your name and email address below to download the registration.

Reimbursement Intelligence Monitor:
Insights for Biocapital Investors Newsletter

Key topics include:

• Medicare Part D and Biologics
• Reimbursement: Closing the Due Diligence Circuit
• Winning P&T Launch Plan
• Off Label Use and Oncology Management Trends

Oncology and Off Label Use: Trends in Management by Health Plans

Article March 14, 2008

Article reviews the current trends in management of high cost oncology agents.

Fill in your name and email address below to read how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Medicare Part D 2008: Implications and Challenges for Biotech Products.
February 21, 2008.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Reimbursement Due Diligence For Biotech Investments. January 11, 2008.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.

The Zangani Investor Community™ interviews
Rhonda Greenapple, President of Reimbursement Intelligence.  

Overview of the formulary process for Biotech and speciality products.

Rhonda answers critical questions for all Biotech or specialty product organizations bringing a product to market.

Fill in your name and email address below to listen in and learn how to help bring your product to approval.